ARPA-H Biomedical Research Agency Gets Funding Boost In US House Appropriations Bill
Executive Summary
Progress on appropriations follows passage of legislation in the House formally authorizing the new agency dedicated to advancing cutting edge research.
You may also be interested in...
BIO’s New CEO Is Biotech Industry Veteran With Compelling Family Story, Ready To Take On The IRA
John Crowley will take the reins at BIO in March, about a year and a half after the departure of former CEO Michelle McMurry-Heath was announced.
Patient-Focused Listening Sessions For Medicare-Negotiated Drugs: Key Takeaways From Round One
Pink Sheet infographic breaks down the mix of patient advocacy groups, individual patients and clinicians offering input to CMS on the first 10 drugs facing Medicare price negotiation.
Copay Accumulators Get A Reprieve: Commercial Plans’ Use Will Not Be Restricted By CMS – Yet
US Health and Human Service Department questions recent federal court decision striking down the government’s policy of allowing plans to broadly exclude manufacturer copay assistance from counting toward patient deductibles or out-of-pocket maximums.